Concepedia

Mireya Wessolossky

MW

Statistics

Publications

11

Citations

488

H-Index

10

Active since

1997

Affiliations

University of Massachusetts Chan Medical School(Current)

National Institute of Allergy and Infectious Diseases

Massachusetts General Hospital

Harvard University

The University of Texas at San Antonio Health Science Center

Mireya Wessolossky is an author at University of Massachusetts Chan Medical School specializing in infectious diseases, medicine, and pharmacotherapy.

Publications per year

1997–2024

11

Publications

11

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson et al. · The Lancet Respiratory Medicine · 2022 · 128 citations · Full text

, , +3

Frequency, Risk Factors, and Outcome for Bacteremia After Percutaneous Transluminal Coronary Angioplasty

Matthew H. Samore, Mireya Wessolossky, Stanley M. Lewis et al. · The American Journal of Cardiology · 1997 · 102 citations

, , +14

Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia

Jane A. O’Halloran, Emily R. Ko, Kevin J. Anstrom et al. · JAMA · 2023 · 67 citations · Full text

, , +11

Methicillin‐Resistant<i>Staphylococcus intermedius</i>Pneumonia Following Coronary Artery Bypass Grafting

Kimberly Gerstadt, Jennifer S. Daly, Michael Mitchell et al. · Clinical Infectious Diseases · 1999 · 49 citations · Full text

, , +10

THE INTESTINAL AND ORAL MICROBIOMES ARE ROBUST PREDICTORS OF COVID-19 SEVERITY THE MAIN PREDICTOR OF COVID-19-RELATED FATALITY

Doyle V. Ward, Shakti K. Bhattarai, Mayra Rojas-Correa et al. · medRxiv · 2021 · 33 citations · Full text

, , +17

1–5 of 11